Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
AC Immune (ACIU) had Non-Operating Income/Expense of $1.29M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$3.99M |
|
$-10.77M |
|
-- |
|
$3.99M |
|
$16.06M |
|
$-12.07M |
|
|
Non-Operating Income/Expense |
$1.29M |
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-10.77M |
|
$-12.07M |
|
-- |
|
67.31M |
|
67.31M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$101.71M |
|
$2.16M |
|
$69.69M |
|
$171.41M |
|
$120.25M |
|
-- |
|
$17.98M |
|
$138.23M |
|
$33.18M |
|
$-28.90M |
|
$33.18M |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|